title: Do molecularly targeted agents in oncology have reduced attrition rates?
authors.forename: Ian
authors.initials: I
authors.lastname: Walker
authors.forename: Herbie
authors.initials: H
authors.lastname: Newell
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D017277:Drug Approval; D015195:Drug Design; D006801:Humans; D009369:Neoplasms / Q000628:therapy*
chemical_list: D000970:Antineoplastic Agents